Twist Bioscience (TWST) Reports Q2 2026 Financial Results
Published on 5/10/2026
AI Summary
Twist Bioscience Corporation (TWST) reported its financial results for Q2 2026. The company achieved revenue growth of 10% year-over-year, reaching $30 million. The gross profit margin for the quarter was reported at 65%. This performance indicates a steady demand for their synthetic DNA products, which could positively influence market confidence in TWST's future growth.
Related News
Earnings
Savara (SVRA) CFO Executes 580,187 Options, Sells 394,528 Shares
Jun 27
Earnings
Bruker Corporation (BRKR) Price Target Raised to $65 by JPMorgan
Jun 27
Earnings
BJ's Restaurants (BJRI) Insider Sells $405,000 in Shares
Jun 27
Earnings
Jack in the Box (JACK) Closes 70 Restaurants as Sales Decline 3.8%
Jun 27